Dimensional Fund Advisors LP Editas Medicine, Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,267,110 shares of EDIT stock, worth $7.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,267,110

Previous 2,345,054 3.32%

Holding current value

$7.44 Million

Previous $11 Million 29.41%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$3.39 - $5.96 $264,230 - $464,546	-77,944 Reduced 3.32%	2,267,110 $7.73 Million
Q2 2024 Aug 09, 2024	SELL	$4.67 - $7.28 $1.23 Million - $1.91 Million	-262,711 Reduced 10.07%	2,345,054 $11 Million
Q1 2024 May 10, 2024	BUY	$7.03 - $11.07 $1.51 Million - $2.38 Million	215,369 Added 9.0%	2,607,765 $19.3 Million
Q4 2023 Feb 07, 2024	BUY	$6.25 - $11.11 $4.31 Million - $7.67 Million	690,366 Added 40.56%	2,392,396 $24.2 Million
Q3 2023 Nov 09, 2023	SELL	$6.92 - $9.31 $451,177 - $607,002	-65,199 Reduced 3.69%	1,702,030 $13.3 Million
Q2 2023 Aug 09, 2023	BUY	$6.36 - $11.47 $988,827 - $1.78 Million	155,476 Added 9.65%	1,767,229 $14.5 Million
Q1 2023 May 12, 2023	SELL	$7.03 - $11.53 $268,946 - $441,103	-38,257 Reduced 2.32%	1,611,753 $11.7 Million
Q4 2022 Feb 09, 2023	BUY	$8.32 - $13.21 $8.27 Million - $13.1 Million	993,508 Added 151.33%	1,650,010 $14.6 Million
Q3 2022 Nov 10, 2022	SELL	$12.16 - $19.42 $468,840 - $748,757	-38,556 Reduced 5.55%	656,502 $8.04 Million
Q2 2022 Aug 12, 2022	SELL	$9.99 - $21.35 $1.72 Million - $3.67 Million	-171,857 Reduced 19.82%	695,058 $8.22 Million
Q1 2022 May 13, 2022	SELL	$14.08 - $27.63 $302,142 - $592,912	-21,459 Reduced 2.42%	866,915 $16.5 Million
Q4 2021 Feb 09, 2022	BUY	$26.55 - $40.57 $4.74 Million - $7.25 Million	178,608 Added 25.16%	888,374 $23.6 Million
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $3.17 Million - $5.89 Million	80,735 Added 12.83%	709,766 $29.2 Million
Q2 2021 Aug 12, 2021	BUY	$31.29 - $56.64 $11.3 Million - $20.4 Million	360,003 Added 133.82%	629,031 $35.6 Million
Q1 2021 May 14, 2021	BUY	$39.71 - $90.58 $6.29 Million - $14.4 Million	158,510 Added 143.42%	269,028 $11.3 Million
Q4 2020 Feb 25, 2021	BUY	$27.07 - $84.35 $2.99 Million - $9.32 Million	110,518 New	110,518 $7.75 Million

Others Institutions Holding EDIT

# of Institutions

242

Shares Held

58.9M

Call Options Held

494K

Put Options Held

417K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $225M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Editas Medicine, Inc. Transaction History